NAMS logo

NAMS Current liabilities

annual current liabilities:

$106.92M+$57.02M(+114.28%)
December 31, 2024

Summary

  • As of today (September 17, 2025), NAMS annual total current liabilities is $106.92 million, with the most recent change of +$57.02 million (+114.28%) on December 31, 2024.
  • During the last 3 years, NAMS annual current liabilities has risen by +$95.73 million (+855.79%).
  • NAMS annual current liabilities is now at all-time high.

Performance

NAMS Current liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNAMSbalance sheet metrics

quarterly current liabilities:

$36.51M-$4.40M(-10.76%)
June 30, 2025

Summary

  • As of today (September 17, 2025), NAMS quarterly total current liabilities is $36.51 million, with the most recent change of -$4.40 million (-10.76%) on June 30, 2025.
  • Over the past year, NAMS quarterly current liabilities has dropped by -$8.79 million (-19.41%).
  • NAMS quarterly current liabilities is now -65.85% below its all-time high of $106.92 million, reached on December 31, 2024.

Performance

NAMS quarterly current liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNAMSbalance sheet metrics

Current liabilities Formula

Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities

NAMS Current liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+114.3%-19.4%
3 y3 years+855.8%+1890.2%
5 y5 years+578.7%+10000.0%

NAMS Current liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+855.8%-65.8%+858.9%
5 y5-yearat high+855.8%-65.8%>+9999.0%
alltimeall timeat high+855.8%-65.8%>+9999.0%

NAMS Current liabilities History

DateAnnualQuarterly
Jun 2025
-
$36.51M(-10.8%)
Mar 2025
-
$40.91M(-61.7%)
Dec 2024
$106.92M(+114.3%)
$106.92M(+159.2%)
Sep 2024
-
$41.26M(-8.9%)
Jun 2024
-
$45.31M(-24.1%)
Mar 2024
-
$59.73M(+1468.5%)
Dec 2023
$49.90M(+38.4%)
-
Dec 2022
$36.06M
-
DateAnnualQuarterly
Sep 2022
-
$3.81M(+107.6%)
Jun 2022
-
$1.83M(+1605.0%)
Mar 2022
-
$107.60K(-51.6%)
Dec 2021
$11.19M(-29.0%)
$222.10K(-9.7%)
Sep 2021
-
$245.90K(+109.3%)
Jun 2021
-
$117.50K(-51.7%)
Mar 2021
-
$243.30K(+2.9%)
Dec 2020
$15.75M
$236.50K

FAQ

  • What is NewAmsterdam Pharma Company N.V. annual total current liabilities?
  • What is the all time high annual current liabilities for NewAmsterdam Pharma Company N.V.?
  • What is NewAmsterdam Pharma Company N.V. annual current liabilities year-on-year change?
  • What is NewAmsterdam Pharma Company N.V. quarterly total current liabilities?
  • What is the all time high quarterly current liabilities for NewAmsterdam Pharma Company N.V.?
  • What is NewAmsterdam Pharma Company N.V. quarterly current liabilities year-on-year change?

What is NewAmsterdam Pharma Company N.V. annual total current liabilities?

The current annual current liabilities of NAMS is $106.92M

What is the all time high annual current liabilities for NewAmsterdam Pharma Company N.V.?

NewAmsterdam Pharma Company N.V. all-time high annual total current liabilities is $106.92M

What is NewAmsterdam Pharma Company N.V. annual current liabilities year-on-year change?

Over the past year, NAMS annual total current liabilities has changed by +$57.02M (+114.28%)

What is NewAmsterdam Pharma Company N.V. quarterly total current liabilities?

The current quarterly current liabilities of NAMS is $36.51M

What is the all time high quarterly current liabilities for NewAmsterdam Pharma Company N.V.?

NewAmsterdam Pharma Company N.V. all-time high quarterly total current liabilities is $106.92M

What is NewAmsterdam Pharma Company N.V. quarterly current liabilities year-on-year change?

Over the past year, NAMS quarterly total current liabilities has changed by -$8.79M (-19.41%)
On this page